Healthco Healthcare and Wellness REIT (hcw) Logo

Healthco Healthcare and Wellness REIT (HCW)

___:___ · Real Estate
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

HCW Chart

Snapshot

HCW's Principal Activity is the owning and managing a portfolio of commercial health and wellness real estate assets.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -14.84%
vs ASX 200 (1yr) -20.77%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 446 of 2,423
Sector Rank 42 of 96

Key Fundamentals

Shares Issued
Sector Real Estate
Similar Companies PPC / QAL / AQR
EPS $0.00
DPS $0.0525
Book Value Per Share $0.00

Broker Consensus

Breakdown 7 Buy · 1 Hold · 0 Sell
Recommendation Strong Buy
Last Updated 29/06/22

Announcements

Date Heading Pages File Size Time

Corporate Overview

HealthCo Healthcare and Wellness REIT (HCW) is a real estate investment trust with a mandate to invest in Hospitals, Aged Care, Childcare, Government, Life Sciences & Research and Primary Care & Wellness property assets, as well as other healthcare and wellness property adjacencies. HealthCo REIT's Portfolio will consist of 27 assets.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Double Bay NSW 2028
Website www.home-co.com.au
Registry Link Market Services
Auditor KPMG Australia Pty Limited
Date Listed 6 Sep 2021

Upcoming Calendar (Forecasted)

Date Event
22/08/2022 Div Pay Date
17/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
29/06/2022 $0.0225 0% $0.0225 Final 22/08/2022
30/03/2022 $0.0225 0% $0.0225 Interim 20/05/2022
30/12/2021 $0.03 0% $0.03 Interim 25/02/2022

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.0525
Gross DPS(TTM) $0.0525
Dividend yield
Gross yield
Payout Ratio --
DRP Yes
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Dr Christopher Graham Roberts Non-Executive Director Aug 2021

Dr Christopher Graham Roberts

Non-Executive Director

Dr Roberts has worked in the medical device industry for over 40 years in a number of senior management positions. He was former CEO of Cochlear from 2004 to 2015 and member of the Cochlear Foundation Board. He was founding director and Executive Vice President of ResMed from 1992 to 2003, and a director until November 2017. He has served as Chair of OncoSil Medical Limited, Chair of TEDI London and non-executive director of Clarity Pharmaceuticals Limited and Atmo Biosciences Pty Ltd. He was also a former Chair of Research Australia (2004 to 2010).

Ms Stephanie Lai Non-Executive Director Aug 2021

Ms Stephanie Lai

Non-Executive Director

Ms Lai has over 20 years' experience as a Chartered Accountant and a former M&A partner of Deloitte and KPMG. She also has experience providing due diligence and advisory services, including forecast reviews to listed entities, sovereign wealth funds, wealth managers and private equity. She is currently serves as independent Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT), Superloop and Future Generation Investment Company. She is a member of the Association of Corporate Counsel Australia. She is also Chair of Risk Committee of HCW.

Hon Kelly Megan O'Dwyer Non-Executive Director Aug 2021

Hon Kelly Megan O'Dwyer

Non-Executive Director

The Hon O'Dwyer has experience in across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is currently serves as independent Non-Executive Director of Home Consortium, EQT Holdings Limited and Barrenjoey Capital Partners Group Holdings Pty Ltd. She has served in the Australian Parliament as a Senior Cabinet Minister holding a number of economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She has also served as Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. She was former member of the Cabinet's Budget Committee (the Expenditure Review Committee). Prior to entering Parliament, he has worked in law, government and finance.

Mr Joseph Carrozzi Non-Executive Chairman,Non-Executive Director Aug 2021

Mr Joseph Carrozzi

Non-Executive Chairman,Non-Executive Director

Mr Carrozzi is a partner in the Big 4 professional services firms for over 20 years, commencing with Tax & Legal Leader at Andersens, Regional Managing Partner at EY and then joining PwC in 2005 as National Managing Partner, Markets and Sydney Office. He has served as Chair of the Centenary Institute for Medical Research, Chair of Sydney Harbour Federation Trust and Deputy Chair of the NSW Institute of Sport. He has also served as Governor on the board of Western Sydney University and Board member of Football Australia. He is also member of Risk Committee of HCW.

Ms Natalie Jane Meyenn Non-Executive Director Aug 2021

Ms Natalie Jane Meyenn

Non-Executive Director

Ms Meyenn has over 25 years' experience in financial services and investing globally. Previously, she held the roles of CIO and Chair of the Investment Committee for MLC Private Equity. She has worked in Investment Banking (M&A, capital markets and public finance) in New York and Sydney for many years and spent time at the World Bank working in Asia, Africa and the Pacific Islands on microfinance, project finance and climate change impact mitigation strategies. She has also served as director and/or shareholder for a small number of asset management and investment businesses in Europe and Australia, including a carbon neutral asset management platform in Australia. She is also proposed director of the fund manager of the Unlisted Fund. She is also member of Risk Committee of HCW.

Mr David Anthony Di Pilla Non-Executive Director Jul 2021

Mr David Anthony Di Pilla

Non-Executive Director

Mr Di Pilla has over 20 years of experience in investment banking. He is currently Managing Director and Chief Executive Officer of Home Consortium, and Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT). He was a founder, director and shareholder of Aurrum. He was a former strategic advisor and Director to operating subsidiaries of the Tenix Group of Companies from 2014 to 2016. From 2004 to 2015, David was Managing Director and Senior Adviser at UBS, Australia and during this time he advised some of Australia's corporations on mergers and acquisitions, debt and equity capital market transactions.

Mr Andrew Selim Company Secretary,General Counsel N/A

Director Transactions

HCW directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
15/06/22 Stephanie Lai Buy +64,000 $1.495 $95,680 On-market trade
05/05/22 David Di Pilla Buy +58,064 $1.891 $109,775 On-market trade
04/05/22 David Di Pilla Buy +1,041,936 $1.957 $2,039,589 On-market trade
03/05/22 David Di Pilla Buy +165,009 $1.941 $320,232 On-market trade
02/05/22 David Di Pilla Buy +241,486 $1.941 $468,651 On-market trade
29/04/22 David Di Pilla Buy +401,018 $1.965 $787,960 On-market trade
28/04/22 David Di Pilla Buy +192,487 $1.95 $375,311 On-market trade
10/03/22 David Di Pilla Buy +509,811 $1.949 $993,537 On-market trade
03/03/22 David Di Pilla Buy +347,960 $1.976 $687,568 On-market trade
02/03/22 David Di Pilla Buy +70,000 $1.911 $133,784 On-market trade
01/03/22 David Di Pilla Buy +93,755 $1.90 $178,134 On-market trade

Director Interests

The current holdings of HCW directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Stephanie Lai 15/06/2022 9,636 164,000 N/A N/A
David Di Pilla 05/05/2022 N/A 68,621,536 N/A N/A
Natalie Meyenn 01/08/2021 24,939 N/A N/A N/A
Joseph Carrozzi 01/08/2021 224,939 N/A N/A N/A
Kelly O'Dwyer 01/08/2021 9,636 25,000 N/A N/A
Christopher Roberts 01/08/2021 9,636 500,000 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 2, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Home Consortium Developments Limited 65,000,010 19.99%
HSBC Custody Nominees (Australia) Limited 47,434,528 14.59%
J P Morgan Nominees Australia Pty Limited 20,259,926 6.23%
National Nominees Limited 19,098,690 5.87%
Citicorp Nominees Pty Limited 17,237,957 5.30%
HSBC Custody Nominees (Australia) Limited A/C 2 12,569,740 3.87%
UBS Nominees Pty Ltd 9,260,226 2.85%
BNP Paribas Noms Pty Ltd (Drp) 4,561,901 1.40%
Netwealth Investments Limited (Wrap Services A/C) 4,441,631 1.37%
BNP Paribas Nominees Pty Ltd (Agency Lending Drp A/C) 3,220,828 0.99%
Warbont Nominees Pty Ltd (Unpaid Entrepot A/C) 2,945,434 0.91%
Custodial Services Limited (Beneficiaries Holding A/C) 1,650,000 0.51%
Seymour Group Pty Ltd 1,650,000 0.51%
Bridgebox Pty Limited (Bridgebox A/C) 1,500,000 0.46%
Sword Equity Investments Pty Ltd 1,375,000 0.42%
Netwealth Investments Limited (Super Services A/C) 1,321,487 0.41%
Goat Properties Pty Ltd 1,250,000 0.38%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (Drp A/C) 1,215,306 0.37%
Premium Capital (Aust) Pty Ltd 1,082,000 0.33%
BNP Paribas Nominees Pty Ltd (Pitcher Partners Drp) 996,010 0.31%
Friday Investments Pty Limited (Goldburg Family Account) 800,000 0.25%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 315 1,816 1,627 2,487 114 6,359

Substantial Shareholders

No Substantial Shareholders for HCW in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
28-03-22 Macquarie Group Limited and its controlled bodies 21,473,604 -- 6.60

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
HCW Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.